Susquehanna Fundamental Investments, LLC Ironwood Pharmaceuticals Inc Transaction History

Susquehanna Fundamental Investments, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$10.14 - $12.38 $835,688 - $1.02 Million	-82,415 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$10.61 - $12.88 $629,968 - $764,750	59,375 Added 257.7%	82,415 $1.04 Million
Q4 2021 Feb 14, 2022	SELL	$10.86 - $13.95 $237,671 - $305,295	-21,885 Reduced 48.71%	23,040 $269,000
Q3 2021 Nov 15, 2021	BUY	$11.92 - $13.92 $86,276 - $100,752	7,238 Added 19.21%	44,925 $587,000
Q2 2021 Aug 11, 2021	BUY	$10.16 - $13.11 $382,899 - $494,076	37,687 New	37,687 $485,000

236

162M

11.2M

9.1K

Ticker IRWD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 153,231,008
Market Cap $607M
Description
Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...

Get notified when there are updates to the investment portfolio of Susquehanna Fundamental Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Susquehanna Fundamental Investments, LLC with notifications on news.